CMPS - COMPASS Pathways plc

NasdaqGS - NasdaqGS Real-time price. Currency in USD

COMPASS Pathways plc

33 Broadwick Street
London W1F 0DQ
United Kingdom
44 71 6676 6461

IndustryMedical Care Facilities
Full-time employees181

Key executives

NameTitlePayExercisedYear born
Mr. George Jay GoldsmithChairman & Co-founder826.37kN/A1954
Mr. Kabir Nath M.A., M.B.A.CEO & Director952.19kN/A1965
Dr. Ekaterina Malievskaia M.D.Co-Founder, Chief Innovation Officer & Exec. Director567.91kN/A1967
Mr. Matthew OwensGen. Counsel & Chief Legal Officer659.53kN/A1978
Mr. Michael F. FalveyChief Financial OfficerN/AN/A1959
Dr. Greg Ryslik Ph.D.Chief Technology OfficerN/AN/AN/A
Mr. Stephen D. SchultzSr. VP of Investor RelationsN/AN/AN/A
Mr. Christopher WilliamsChief Communications OfficerN/AN/AN/A
Ms. Anne BenedictChief People OfficerN/AN/AN/A
Mr. Lars Christian WildeSr. AdvisorN/AN/A1985
Amounts are as of 31 December 2022, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


COMPASS Pathways plc operates as a mental health care company primarily in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy that is in Phase III clinical trials for the treatment of treatment-resistant depression; and is in Phase II clinical trials for the treatment of post-traumatic stress disorder and anorexia nervosa. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020. COMPASS Pathways plc was incorporated in 2020 and is headquartered in London, the United Kingdom.

Corporate governance

COMPASS Pathways plc’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.